当前位置: X-MOL 学术Pediatr. Hematol. Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Analysis of survival rates and prognosis of hepatoblastoma in children: a retrospective study from a single center in China
Pediatric Hematology and Oncology ( IF 1.7 ) Pub Date : 2021-03-05 , DOI: 10.1080/08880018.2020.1867266
Jie Liu 1, 2 , Xiong-Wei Wu 1 , Tong Li 1 , Xi-Wei Hao 1 , Yu-He Duan 1 , Jing Zhao 1 , Cheng-Zhan Zhu 3 , Bin Wei 3 , Qian Dong 1
Affiliation  

Abstract

Hepatoblastoma (HB) is the most common liver cancer in children, this study aims at analyzing the prognostic factors affecting the survival rates and summarizing the treatment experience. In this study, we reviewed patients with primary HB under the age of 14 years who underwent complete tumor resection from June 1997 to March 2019. The data of 72 patients were collected. Survival analysis was performed by Kaplan-Meier, multivariate Cox proportional hazards regression and linear mixed model for repeated measures (LMMRM). The 5-year and the 10-year event-free survival (EFS) of all patients were 78.2% and 73%, respectively. Both the 5-year and 10-year overall survival (OS) were 85.7%. Kaplan-Meier survival analysis showed that patients with tumor capsule infiltration (TCI) and patients with surgical margin less than 1 cm may also have a good prognosis. The Cox proportional hazards regression model analysis results were similar to the Kaplan-Meier analysis results. LMMRM analysis showed that there were significant differences in platelet, alpha-fetoprotein, C-reactive protein and hemoglobin values after surgery in the metastasis group (P < 0.05). This study suggests that patients with TCI or narrow surgical margin (<1 cm) may also have a good prognosis, and the risk stratification of HB can be used as the latest grading standard to evaluate the prognosis of patients.

更新日期:2021-05-07
down
wechat
bug